DOI: http://dx.doi.org/10.18203/2349-2902.isj20185044

A clinic-pathological prospective study of operable carcinoma breast

Ahila Muthuselvi, Umarani Subramanian, Vinodh Duraisami

Abstract


Background: Cancer breast is the leading cause of site-specific cancer-related death next to cancer cervix for women aged 20-59 years. Early diagnosis and treatment will reduce the morbidity and mortality of the disease and thus prolongs the survival of the patient. The patient usually present in the later stages of disease, due to the lack of awareness. This study aims at studying the various type of clinical and pathological patterns of presentation of operable carcinoma breast in a tertiary care centre.

Methods: 50 patients with Carcinoma Breast, admitted in Government Royapettah Hospital were studied. It was a cross-sectional prospective study performed from January 2016 to October 2017.

Results: The average age of occurrence of operable carcinoma breast is 48.54 years. One patient had a positive family history. Lump (100%) is the most commonest presentation. 98% of the study population had Infiltrating ductal carcinoma as HPE report. In my study population 56 % of had stage II disease. Patient with Early breast cancer underwent surgery followed by adjuvant chemotherapy, hormonal therapy, and radiotherapy. Patient with stage III disease undergoes neoadjuvant chemotherapy followed by surgery, then adjuvant chemotherapy, hormonal therapy, radiotherapy.

Conclusions: The incidence of operable carcinoma breast is more common among middle-aged groups. The commonest presenting complaint is a lump and commonest histopathological type is infiltrating ductal carcinoma. Multimodality modality manage is the optimum treatment adopted. Routine screening mammography and by the health awareness programme carcinoma breast, nowadays, detected at an earlier stage.


Keywords


Breast conservation, Operable carcinoma breast, Self-breast examination

Full Text:

PDF

References


Williams NS, O’Connell PR, McCaskie AW. Short practice of surgery Bailey and Love 26th edition. CRC press; 2013.

Brunicardi FC, Anderson DK, Billiar TR, Dunn DL, Hunter JG, Mathews JB, et al. Schwartz’s principles of surgery 9th edition, McGraw-Hill Professional; 2009.

Schaake- Koning C, van der Linden EH, Hart G, Engelsman E. Adjuvant chemo and hormonal therapy in locally advanced breast cancer: a randomized clinical study. Int J Radiat Oncol Biol Phys. 1985;11(10):1759-63

Chandra AB. Problems and prospects of cancer of the breast in India. J Indian Med Assoc. 1979;72:43-5.

Kuraparathy S, Reddy KM, Yadagiri LA, Yutla M, Venkata PB, Kadainti SV, et al. Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in southern India. World J Surg Oncol. 2007;5:56.

Rosai RJ. Ackerman’s Surgical Pathology. 10th ed. Chapter 20, New Delhi: Reed Elsevier India Private Limited;2011:1659-1770.

Van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, et al. Expression of cytokeratins 17 and 15 identifies a group of breast carcinomas with the poor clinical outcome. Am J Pathol. 2002;161(6):1991-6.

Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS. The spectrum of breast cancer in Asian women. World J Surg. 2007:31:1031-40

AJCC Cancer Staging Manual. 6th ed. Chicago, Illinois USA: Springer;2002:227-228.

Akhtar M, Akulwar V, Gandhi D, Chandak K. Is locally advanced breast cancer neglected disease?. Indian J Cancer. 2011;48:403-5

Greenall MJ, Wood WC. Cancer of the breast. In: Morris PJ. Wood WC, eds Oxford Textbook of Surgery. Vol 2. 2nd Ed. New York; Oxford University Press Inc;2000:1191.

Haagensen C, Stout A. Carcinoma of the breast II-criteria of operability. Ann Surg. 1943;118:1032-51.

Kakarala M, Rozek L, Cote M, Liyanage S, Brenner DE. Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.-a SEER analysis. BMC Cancer. 2010;10:191.

Toniolo PG, Levitz M, Zeleniuch-Jacquotte. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst. 1995;87:190-7.

Spicer DV, Pike MC. Sex steroids and breast cancer prevention. Monogr Natl Cancer Inst. 1994;16:139-47.

Sainsbury RC. The Breast. In Russell RCG, Bulstrode CJK, Williams NS. eds. Bailey and Love’s Short practice of surgery. 24th ed. London; Hodder Education; 2004: 837.

Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Patient delay and stage of diagnosis among breast cancer patients in Germany-a population based study. Br J Cancer. 2002;86(7):1034-40.